2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Stock Value | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | NA | NA | 0.00 | NA | |
Weighted Average Number Of Diluted Shares Outstanding | 52.25 | 51.38 | 50.13 | NA | 48.77 | 48.34 | 0.05 | NA | 40.77 | 40.52 | 0.04 | NA | NA | NA | NA | NA | NA | |
Weighted Average Number Of Shares Outstanding Basic | 52.24 | 51.37 | 50.11 | NA | 48.77 | 48.34 | 0.05 | NA | 40.77 | 40.52 | 0.04 | NA | NA | NA | NA | NA | NA | |
Earnings Per Share Basic | -1.08 | -4.40 | -3.20 | -4.40 | -6.40 | -3.60 | -4.40 | -2.40 | -16.40 | -16.40 | -14.80 | -46.80 | -3.20 | -1.60 | NA | NA | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Excluding Assessed Tax | 89.05 | 56.21 | 37.94 | 34.76 | 55.43 | 80.57 | 80.70 | 98.28 | 66.40 | 144.62 | 168.41 | 148.49 | 77.61 | 43.64 | 44.10 | 32.06 | 13.30 | |
Gain Loss On Investments | -6.91 | -6.83 | -2.54 | -10.01 | -36.32 | -2.12 | -6.37 | -13.35 | -1.76 | -38.67 | 0.45 | -14.55 | -12.37 | 2.75 | 12.62 | 1.25 | -0.09 | |
Operating Expenses | 144.25 | 279.15 | 215.95 | 212.87 | 341.82 | 264.72 | 296.45 | 332.79 | 719.42 | 791.53 | 842.92 | 1833.23 | 104.28 | 103.58 | 101.21 | 87.95 | 47.72 | |
Research And Development Expense | 77.01 | 134.22 | 136.46 | 117.04 | 156.66 | 144.28 | 162.64 | 181.16 | 259.58 | 289.19 | 322.72 | 985.02 | 53.02 | 52.03 | 59.59 | 61.19 | 36.07 | |
General And Administrative Expense | 52.29 | 66.28 | 70.29 | 89.22 | 82.03 | 102.34 | 111.43 | 121.42 | 435.18 | 438.43 | 434.77 | 781.63 | 28.96 | 5.31 | 17.93 | 12.91 | 9.88 | |
Operating Income Loss | -55.20 | -222.94 | -178.00 | -178.12 | -286.39 | -184.15 | -215.75 | -234.51 | -653.02 | -646.91 | -674.51 | -1684.73 | -26.67 | -5.31 | -57.12 | -55.89 | -34.41 | |
Allocated Share Based Compensation Expense | 13.86 | 37.15 | 40.78 | 42.84 | 52.57 | 61.49 | 72.99 | 108.17 | 563.14 | 606.51 | 652.82 | 1667.80 | 0.13 | 14.52 | 0.12 | 0.12 | 0.12 | |
Income Tax Expense Benefit | -0.38 | 0.19 | 0.03 | -0.20 | -0.02 | 0.07 | 0.08 | -14.77 | -0.03 | -0.04 | -0.18 | -0.68 | -0.21 | -0.43 | -0.16 | 0.01 | 0.01 | |
Net Income Loss | -56.40 | -217.18 | NA | -211.69 | -302.89 | -173.31 | -204.97 | -176.54 | -669.05 | -668.83 | -590.50 | -1600.66 | -101.88 | -106.76 | 5.76 | -46.92 | -26.05 | |
Comprehensive Income Net Of Tax | -54.42 | -217.35 | -168.95 | -207.31 | -304.49 | -173.00 | -203.95 | -168.88 | -671.47 | -673.71 | -593.23 | -1605.83 | -103.28 | -54.46 | -74.78 | -46.40 | -26.13 | |
Goodwill Impairment Loss | 0.00 | 47.86 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | 1480.88 | 1625.26 | 1581.76 | 1665.34 | 2026.39 | 2292.00 | 2417.21 | 2539.32 | 1870.69 | 1994.22 | 2057.73 | 2070.99 | 2150.59 | 1725.99 | 1728.03 | 1.25 | NA | |
Liabilities | 682.94 | 792.18 | 594.49 | 568.19 | 773.71 | 788.41 | 809.62 | 803.04 | 430.96 | 427.16 | 443.68 | 503.61 | 532.62 | 254.95 | 150.14 | 1.23 | NA | |
Liabilities And Stockholders Equity | 1480.88 | 1625.26 | 1581.76 | 1665.34 | 2026.39 | 2292.00 | 2417.21 | 2539.32 | 1870.69 | 1994.22 | 2057.73 | 2070.99 | 2150.59 | 1725.99 | 1728.03 | 1.25 | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | 662.48 | 783.36 | 903.02 | 1001.75 | 1141.85 | 1223.45 | 1327.31 | 1450.08 | 1462.00 | 1598.85 | 1705.83 | 1723.05 | 1810.57 | 0.97 | NA | 426.54 | NA | |
Cash And Cash Equivalents At Carrying Value | 616.21 | 730.37 | 840.44 | 944.07 | 1049.24 | 1105.79 | 1206.09 | 1315.79 | 1302.60 | 1377.15 | 1492.97 | 1550.00 | 1739.06 | 0.04 | 1.92 | 0.00 | 471.06 | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 661.54 | 775.74 | 887.21 | 989.58 | 1094.62 | 1172.06 | 1258.67 | 1369.58 | 1345.51 | 1420.84 | 1535.85 | 1592.93 | 1765.30 | 253.30 | 314.27 | 385.88 | 474.23 | |
Accounts Receivable Net Current | 23.41 | 18.59 | 24.19 | 17.16 | 61.90 | 68.02 | 83.26 | 80.91 | 113.66 | 171.62 | 167.26 | 131.54 | 44.67 | NA | NA | 16.69 | NA | |
Prepaid Expense And Other Assets Current | 22.32 | 34.10 | 38.02 | 39.78 | 29.39 | 48.36 | 33.87 | 47.46 | 37.78 | 38.72 | 33.09 | 33.54 | 17.31 | NA | NA | 21.10 | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Property Plant And Equipment Gross | 361.77 | 346.81 | 326.08 | 308.91 | 322.31 | 412.71 | 421.23 | 407.53 | 271.01 | 254.43 | 218.95 | 206.82 | 196.54 | NA | NA | 155.21 | NA | |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 150.74 | 136.23 | 130.09 | 120.72 | 120.71 | 118.47 | 107.26 | 92.76 | 83.43 | 78.21 | 69.78 | 61.05 | 53.84 | NA | NA | 33.78 | NA | |
Amortization Of Intangible Assets | 4.90 | 4.90 | 3.40 | 3.50 | 4.00 | 4.00 | 4.30 | 3.30 | 1.00 | 0.80 | 0.40 | 0.50 | 0.40 | 0.20 | 0.10 | 0.10 | 0.10 | |
Property Plant And Equipment Net | 211.03 | 210.58 | 195.99 | 188.19 | 201.59 | 294.24 | 313.97 | 314.77 | 187.58 | 176.22 | 149.17 | 145.77 | 142.70 | NA | NA | 121.44 | NA | |
Intangible Assets Net Excluding Goodwill | 79.57 | 90.60 | 77.41 | 82.74 | 100.17 | 105.03 | 108.74 | 111.04 | 47.94 | 39.18 | 20.83 | 21.64 | 22.57 | NA | NA | 3.29 | NA | |
Finite Lived Intangible Assets Net | 79.57 | 90.60 | 77.41 | 82.74 | 100.17 | 105.03 | 108.74 | 111.04 | 47.94 | NA | NA | NA | NA | NA | NA | NA | NA | |
Other Assets Noncurrent | 59.79 | 60.21 | 60.63 | 58.05 | 97.02 | 97.95 | 97.26 | 88.72 | 43.93 | 53.02 | 49.62 | 43.99 | 26.80 | NA | NA | 5.60 | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liabilities Current | 114.43 | 166.15 | 169.04 | 163.86 | 168.46 | 163.33 | 191.70 | 172.96 | 124.82 | 135.02 | 159.25 | 134.76 | 90.31 | 4.69 | 1.42 | 1.23 | NA | |
Accounts Payable Current | 15.70 | 23.03 | 27.00 | 9.32 | 10.75 | 13.63 | 21.57 | 10.45 | 11.32 | 19.46 | 35.26 | 8.19 | 7.10 | NA | NA | 13.89 | NA | |
Contract With Customer Liability Current | 22.89 | 26.01 | 33.61 | 44.49 | NA | NA | NA | 47.82 | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Liabilities Noncurrent | 17.67 | 20.89 | 24.88 | 18.73 | 19.32 | 20.10 | 29.34 | 31.19 | 34.92 | 36.11 | 16.88 | 35.99 | 33.11 | NA | NA | 3.03 | NA | |
Operating Lease Liability Noncurrent | 445.59 | 452.26 | 234.50 | 221.84 | 403.66 | 410.94 | 404.10 | 413.26 | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 797.94 | 833.07 | 987.27 | 1097.15 | 1252.68 | 1503.59 | 1607.59 | 1736.28 | 1439.74 | 1567.06 | 1614.05 | 1567.38 | 1617.97 | 355.79 | 395.57 | 470.05 | 516.33 | |
Common Stock Value | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | NA | NA | 0.00 | NA | |
Additional Paid In Capital | 6527.70 | 6508.21 | 6445.06 | 6386.00 | 6334.22 | 6280.63 | 6211.63 | 6136.38 | 5668.79 | 5098.02 | 4471.42 | 3804.84 | 2249.55 | 105.99 | NA | 0.02 | NA | |
Retained Earnings Accumulated Deficit | -5730.02 | -5673.62 | -5456.44 | -5290.53 | -5078.83 | -4775.94 | -4602.63 | -4397.66 | -4226.31 | -3557.26 | -2888.43 | -2297.93 | -697.27 | -101.00 | 4.99 | -0.01 | NA | |
Accumulated Other Comprehensive Income Loss Net Of Tax | 0.26 | -1.72 | -1.55 | 1.48 | -2.90 | -1.30 | -1.61 | -2.63 | -7.91 | -5.50 | -2.35 | -1.72 | -0.88 | NA | NA | NA | NA | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 13.86 | 37.15 | 40.78 | 42.85 | 52.57 | 62.47 | 72.98 | 108.16 | 563.14 | 606.59 | 669.59 | 1564.64 | 0.13 | 14.52 | 0.12 | NA | 0.12 |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -103.50 | -84.39 | -89.26 | -57.83 | -73.55 | -73.53 | -90.58 | -104.70 | -28.30 | -99.30 | -19.90 | -165.54 | -85.50 | 45.36 | -48.13 | -59.34 | NA | |
Net Cash Provided By Used In Investing Activities | -10.20 | -26.84 | -12.11 | -46.67 | -3.38 | -11.22 | -19.41 | 29.74 | -46.49 | -14.66 | -35.98 | 4.23 | 1647.39 | -1701.83 | -23.05 | -28.83 | NA | |
Net Cash Provided By Used In Financing Activities | -0.47 | -0.23 | -0.84 | -0.63 | -0.32 | -1.38 | -0.89 | 97.93 | -0.45 | -0.95 | -1.19 | -11.04 | -182.50 | 1728.12 | -0.43 | -0.19 | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -103.50 | -84.39 | -89.26 | -57.83 | -73.55 | -73.53 | -90.58 | -104.70 | -28.30 | -99.30 | -19.90 | -165.54 | -85.50 | 45.36 | -48.13 | -59.34 | NA | |
Net Income Loss | -56.40 | -217.18 | NA | -211.69 | -302.89 | -173.31 | -204.97 | -176.54 | -669.05 | -668.83 | -590.50 | -1600.66 | -101.88 | -106.76 | 5.76 | -46.92 | -26.05 | |
Increase Decrease In Accounts Receivable | 5.00 | -5.67 | 6.77 | -28.90 | -22.97 | 0.00 | 1.80 | -34.50 | NA | NA | NA | 86.26 | NA | NA | NA | 7.89 | NA | |
Share Based Compensation | 13.86 | 37.15 | 40.78 | 42.84 | 52.57 | 61.49 | 72.99 | 108.17 | 563.14 | 606.51 | 652.82 | 1591.26 | 0.13 | 14.52 | 0.12 | 0.12 | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | -10.20 | -26.84 | -12.11 | -46.67 | -3.38 | -11.22 | -19.41 | 29.74 | -46.49 | -14.66 | -35.98 | 4.23 | 1647.39 | -1701.83 | -23.05 | -28.83 | NA | |
Payments To Acquire Property Plant And Equipment | 15.09 | 27.03 | 6.71 | 3.45 | 4.38 | 13.53 | 19.44 | 25.64 | 13.47 | 9.57 | 3.58 | 5.11 | 5.44 | 24.03 | 21.93 | 19.41 | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | -0.47 | -0.23 | -0.84 | -0.63 | -0.32 | -1.38 | -0.89 | 97.93 | -0.45 | -0.95 | -1.19 | -11.04 | -182.50 | 1728.12 | -0.43 | -0.19 | NA |
2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Excluding Assessed Tax | 89.05 | 56.21 | 37.94 | 34.76 | 55.43 | 80.57 | 80.70 | 98.28 | 66.40 | 144.62 | 168.41 | 148.49 | 77.61 | 43.64 | 44.10 | 32.06 | 13.30 | |
Allonnia, Related Party | 0.39 | NA | 0.06 | 0.10 | 0.18 | 0.16 | 0.09 | 0.09 | 0.58 | NA | NA | NA | NA | NA | NA | NA | NA | |
Arcaea, Related Party | 0.00 | 4.65 | NA | 0.35 | -0.03 | 4.23 | 1.46 | 3.18 | 4.01 | NA | NA | NA | NA | NA | NA | NA | NA | |
Ayana, Related Party | 0.24 | 0.28 | 0.15 | 0.36 | 0.33 | 0.18 | 0.45 | 0.58 | 0.69 | NA | NA | NA | NA | NA | NA | NA | NA | |
Biomedit, Related Party | 0.27 | NA | NA | -0.24 | 0.63 | 0.87 | 0.91 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Genomatica, Related Party | 0.34 | 0.21 | 0.37 | 1.23 | 1.01 | 0.78 | 1.21 | 2.36 | 2.74 | NA | NA | NA | NA | NA | NA | NA | NA | |
Motif, Related Party | 45.43 | 0.00 | 0.02 | 0.35 | 6.30 | 0.00 | NA | 0.01 | 0.08 | NA | NA | NA | NA | NA | NA | NA | NA | |
Other Equity Investee, Related Party | 0.00 | 0.00 | 0.14 | NA | 0.20 | 0.20 | 0.15 | NA | 0.41 | NA | NA | NA | NA | NA | NA | NA | NA | |
Cell Engineering Revenue | 75.09 | 36.20 | 27.89 | 26.98 | 37.18 | 45.28 | 34.10 | 53.26 | 24.68 | 44.24 | 21.49 | NA | NA | NA | NA | NA | NA | |
Service | 13.96 | 20.00 | 10.05 | 7.78 | 11.76 | 24.50 | 34.94 | 32.60 | 36.53 | 96.49 | 132.97 | 105.92 | 34.38 | 21.69 | 15.82 | 6.93 | 1.80 | |
Related Party | 46.66 | 5.15 | 0.73 | 2.31 | 8.73 | 6.51 | 4.70 | 7.26 | 10.03 | NA | NA | NA | NA | NA | NA | NA | NA | |
Biosecurity | 13.96 | 20.00 | 10.05 | 7.78 | 18.25 | 35.28 | 46.61 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Cell Engineering | 75.09 | 36.20 | 27.89 | 26.98 | 37.18 | 45.28 | 34.10 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Cell Engineering And Biosecurity | 89.05 | 56.21 | 37.94 | NA | 55.43 | 80.57 | 80.70 | NA | 66.40 | NA | NA | NA | NA | NA | NA | NA | NA |